Skip to main content

Published locations for Dapagliflozin’s cost-effectiveness ‘intermediate’ for HFrEF

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Dapagliflozin’s cost-effectiveness ‘intermediate’ for HFrEF

User login

  • Reset your password
  • /content/dapagliflozins-cost-effectiveness-intermediate-hfref
  • /familypracticenews/article/241031/heart-failure/dapagliflozins-cost-effectiveness-intermediate-hfref
  • /fedprac/article/241031/heart-failure/dapagliflozins-cost-effectiveness-intermediate-hfref
  • /internalmedicinenews/article/241031/heart-failure/dapagliflozins-cost-effectiveness-intermediate
  • /clinicalendocrinologynews/article/241031/heart-failure/dapagliflozins-cost-effectiveness
  • /ecardiologynews/article/241031/heart-failure/dapagliflozins-cost-effectiveness-intermediate-hfref
  • /cardiology/article/241031/heart-failure/dapagliflozins-cost-effectiveness-intermediate-hfref
  • /endocrinology/article/241031/heart-failure/dapagliflozins-cost-effectiveness-intermediate-hfref
  • /internalmedicine/article/241031/heart-failure/dapagliflozins-cost-effectiveness-intermediate-hfref
  • /familymedicine/article/241031/heart-failure/dapagliflozins-cost-effectiveness-intermediate-hfref
  • /emergencymedicine/article/241031/heart-failure/dapagliflozins-cost-effectiveness-intermediate-hfref
  • /chestphysician/article/241031/heart-failure/dapagliflozins-cost-effectiveness-intermediate-hfref
  • /type-2-diabetes-icymi/article/241031/heart-failure/dapagliflozins-cost-effectiveness-intermediate